Core Viewpoint - Aier Eye Hospital's stock price has experienced a slight decline, reflecting market fluctuations and investor sentiment towards the company’s strategic direction in the eye care industry [1] Company Overview - Aier Eye Hospital is a leading ophthalmology medical chain in China, providing services that include eye diagnosis, surgery, and optical services [1] - The company has adopted a growth strategy that combines self-built facilities and acquisitions, expanding its medical institutions globally [1] Management Strategy - The management has emphasized a cautious approach to acquisitions, highlighting the need for a robust quality control and management system before pursuing new opportunities [1] - Director Wu Shijun stated that it is essential to avoid blind following of market trends and to maintain a safety margin in their strategies [1] Financial Performance - As of August 6, 2025, Aier Eye Hospital's stock price was reported at 12.82 yuan, with a trading volume of 535,300 hands and a total transaction amount of 686 million yuan [1] - The company held its second extraordinary general meeting in 2025, which approved the completion of certain fundraising projects [1] - As of March 31, 2025, the total number of shareholders was 347,300 [1] Market Activity - On August 6, 2025, the net outflow of main funds was 82.86 million yuan, with a cumulative net outflow of 459 million yuan over the past five days [1]

Group 1 - The stock price of Puri Eye Hospital on August 5 was 41.74 yuan, a decrease of 0.01 yuan or 0.02% from the previous trading day [1] - The opening price on that day was 41.79 yuan, with a highest point of 42.14 yuan and a lowest point of 41.41 yuan, resulting in a trading volume of 16,400 lots and a transaction amount of 0.68 billion yuan [1] - The company experienced a net outflow of main funds amounting to 231.10 thousand yuan, which accounted for 0.04% of its circulating market value on August 5 [1] Group 2 - Puri Eye Hospital operates in the medical services industry, specializing in ophthalmic medical services as a chain institution [1] - The company's main business includes ophthalmic diagnosis and treatment, optometry services, and ophthalmic medical investment management, with a strong market presence in the Sichuan region [1] - Over the past five trading days, the cumulative net outflow reached 29.22 million yuan, representing 0.47% of its circulating market value [1]